JOYCE MCCOOK: Open Payments
NPI 1982005682 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 16 payments from 8 companies in 2025. Trend: 2023 $750 · 2024 $885 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $124 |
| Alkermes, Inc. | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Teva Pharmaceuticals USA, Inc. | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: INGREZZA, ARISTADA, COBENFY, UZEDY, FANAPT, REXULTI, CAPLYTA, VRAYLAR.
Industry payments across GA — which companies pay providers there.
